Related Experiment Videos
The clinical spectrum of pulmonary aspergillosis
Ayman O Soubani1, Pranatharthi H Chandrasekar
1Division of Pulmonary, Critical Care, and Sleep Medicine, Wayne State University School of Medicine, Detroit, MI 48201, USA. asoubani@intmed.wayne.edu
Abstract:
Aspergillus is a ubiquitous fungus that causes a variety of clinical syndromes in the lung, ranging from aspergilloma in patients with lung cavities, to chronic necrotizing aspergillosis in those who are mildly immunocompromised or have chronic lung disease. Invasive pulmonary aspergillosis (IPA) is a severe and commonly fatal disease that is seen in immunocompromised patients, while allergic bronchopulmonary aspergillosis is a hypersensitivity reaction to Aspergillus antigens that mainly affects patients with asthma. In light of the increasing risk factors leading to IPA, such as organ transplantation and immunosuppressive therapy, and recent advances in the diagnosis and treatment of Aspergillus-related lung diseases, it is essential for clinicians to be familiar with the clinical presentation, diagnostic methods, and approach to management of the spectrum of pulmonary aspergillosis.
Insights
Aspergillus fungi cause lung diseases like aspergilloma and invasive pulmonary aspergillosis (IPA). Clinicians need updated knowledge on diagnosing and managing these Aspergillus-related lung conditions.
Area of Science:
- Pulmonology
- Mycology
- Infectious Diseases
Background:
- Aspergillus is a common fungus causing diverse lung conditions.
- Conditions range from aspergilloma to invasive pulmonary aspergillosis (IPA) and allergic bronchopulmonary aspergillosis.
- Increasing immunocompromised populations due to transplants and therapies raise IPA risk.
Purpose of the Study:
- To review the spectrum of Aspergillus-related lung diseases.
- To highlight recent diagnostic and treatment advances.
- To emphasize the need for clinical familiarity with pulmonary aspergillosis.
Main Methods:
- Literature review of Aspergillus-related lung diseases.
- Analysis of clinical presentations.
- Summary of diagnostic and management strategies.
Main Results:
- Aspergillus causes conditions from aspergilloma to IPA and allergic bronchopulmonary aspergillosis.
- IPA is severe and often fatal in immunocompromised individuals.
- Allergic bronchopulmonary aspergillosis is a hypersensitivity reaction in asthma patients.
Conclusions:
- Pulmonary aspergillosis presents diversely, from chronic to invasive forms.
- Clinicians must be aware of risk factors, diagnosis, and management.
- Updated knowledge is crucial for effective patient care in the face of evolving risk factors.